Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

More research needed to confirm finasteride as standard treatment for FFA.

Blimp1 is crucial for hair follicle growth and skin health.

Combining bromelain with finasteride improves hair regrowth and reduces inflammation in alopecia.

Fenugreek extract may help treat benign prostatic hyperplasia.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

5alpha-reductase 2 is crucial for proper male brain development and sexual differentiation.

Finasteride effectively reduced priapism episodes in children with sickle cell disease without side effects.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Quickly get finasteride from tablets using easy methods.

Taking sildenafil and finasteride together is safe and improves urinary and sexual symptoms in BPH patients.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Finasteride may help treat recurrent priapism in sickle cell anemia.

Finasteride complexes with HPβCD and polymers improve solubility, potentially enhancing hair loss treatment.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Researchers created a skin treatment that could effectively deliver medication into hair follicles.